Home/Filings/4/0000950170-25-090452
4//SEC Filing

Siegel Jonathan B. 4

Accession 0000950170-25-090452

CIK 0001585608other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:42 PM ET

Size

11.2 KB

Accession

0000950170-25-090452

Insider Transaction Report

Form 4
Period: 2025-06-24
Transactions
  • Disposition to Issuer

    Convertible Promissory Note

    2025-06-24$50000.00/sh9,000$450,000,0000 total(indirect: See footnote)
    Exercise: $5.55Common Stock (9,000 underlying)
  • Award

    Convertible Promissory Note

    2025-06-24$50000.00/sh+9,462$473,100,0009,462 total(indirect: See footnote)
    Exercise: $5.55Common Stock (9,462 underlying)
  • Award

    Warrant to Purchase Common Stock

    2025-06-24+18,2629,000 total(indirect: See footnote)
    Exercise: $2.70Exp: 2026-12-24Common Stock (18,262 underlying)
Footnotes (3)
  • [F1]The reporting person disposed of a 6% convertible promissory note maturing on 6/30/2025 (the "Original Note") that was originally issued to pursuant to a securities purchase agreement between Jaguar Health, Inc. (the "Company") and the reporting person dated March 26, 2025 in exchange for a new 6% convertible promissory note that matures on 1/30/2026 (the "New Note") in an issuer exchange offer. The New Note is convertible, at the reporting person's option, in part or in full, into an aggregate of 9,462 shares of the Company's voting common stock, par value $0.0001 per share (the "Common Stock"), at a conversion price of $5.555 per share.
  • [F2]As an inducement to enter into the issuer exchange offer, the reporting person received a warrant (the "Warrant") to purchase up to 18,262 shares of Common Stock with an exercise price of $2.70 per share. The Warrant is exercisable immediately upon receipt of stockholder approval and will expire on the earlier of (i) 18 months from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event.
  • [F3]Securities held directly by JBS Healthcare Ventures LLC. Mr. Siegel, by virtue of his position as the sole member of JBS Healthcare Ventures LLC, may be deemed to beneficially own the securities held by JBS Healthcare Ventures LLC for purposes of Section 16

Documents

1 file

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001588209

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:42 PM ET
Size
11.2 KB